These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 15659544)

  • 1. Inhibition of cardiac lipoprotein utilization by transgenic overexpression of Angptl4 in the heart.
    Yu X; Burgess SC; Ge H; Wong KK; Nassem RH; Garry DJ; Sherry AD; Malloy CR; Berger JP; Li C
    Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1767-72. PubMed ID: 15659544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Angptl4 upregulates cholesterol synthesis in liver via inhibition of LPL- and HL-dependent hepatic cholesterol uptake.
    Lichtenstein L; Berbée JF; van Dijk SJ; van Dijk KW; Bensadoun A; Kema IP; Voshol PJ; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2420-7. PubMed ID: 17761937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transgenic angiopoietin-like (angptl)4 overexpression and targeted disruption of angptl4 and angptl3: regulation of triglyceride metabolism.
    Köster A; Chao YB; Mosior M; Ford A; Gonzalez-DeWhitt PA; Hale JE; Li D; Qiu Y; Fraser CC; Yang DD; Heuer JG; Jaskunas SR; Eacho P
    Endocrinology; 2005 Nov; 146(11):4943-50. PubMed ID: 16081640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cardiac Angptl4 by dietary fatty acids is mediated by peroxisome proliferator-activated receptor beta/delta and protects against fatty acid-induced oxidative stress.
    Georgiadi A; Lichtenstein L; Degenhardt T; Boekschoten MV; van Bilsen M; Desvergne B; Müller M; Kersten S
    Circ Res; 2010 Jun; 106(11):1712-21. PubMed ID: 20378851
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of triglyceride metabolism by Angiopoietin-like proteins.
    Mattijssen F; Kersten S
    Biochim Biophys Acta; 2012 May; 1821(5):782-9. PubMed ID: 22063269
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of lipoprotein lipase by Angptl4.
    Dijk W; Kersten S
    Trends Endocrinol Metab; 2014 Mar; 25(3):146-55. PubMed ID: 24397894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perfusion of hearts with triglyceride-rich particles reproduces the metabolic abnormalities in lipotoxic cardiomyopathy.
    Pillutla P; Hwang YC; Augustus A; Yokoyama M; Yagyu H; Johnston TP; Kaneko M; Ramasamy R; Goldberg IJ
    Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1229-35. PubMed ID: 15701679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac lipoprotein lipase activity in the hypertrophied heart may be regulated by fatty acid flux.
    Hauton D; Caldwell GM
    Biochim Biophys Acta; 2012 Apr; 1821(4):627-36. PubMed ID: 22226882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The acute phase response stimulates the expression of angiopoietin like protein 4.
    Lu B; Moser A; Shigenaga JK; Grunfeld C; Feingold KR
    Biochem Biophys Res Commun; 2010 Jan; 391(4):1737-41. PubMed ID: 20043872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic intermittent hypoxia on triglyceride uptake in different tissues.
    Yao Q; Shin MK; Jun JC; Hernandez KL; Aggarwal NR; Mock JR; Gay J; Drager LF; Polotsky VY
    J Lipid Res; 2013 Apr; 54(4):1058-65. PubMed ID: 23386706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipoprotein lipase and angiopoietin-like 4 - Cardiomyocyte secretory proteins that regulate metabolism during diabetic heart disease.
    Puthanveetil P; Wan A; Rodrigues B
    Crit Rev Clin Lab Sci; 2015; 52(3):138-49. PubMed ID: 25597500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mouse model of lipotoxic cardiomyopathy.
    Chiu HC; Kovacs A; Ford DA; Hsu FF; Garcia R; Herrero P; Saffitz JE; Schaffer JE
    J Clin Invest; 2001 Apr; 107(7):813-22. PubMed ID: 11285300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiopoietin-like 4 promotes intracellular degradation of lipoprotein lipase in adipocytes.
    Dijk W; Beigneux AP; Larsson M; Bensadoun A; Young SG; Kersten S
    J Lipid Res; 2016 Sep; 57(9):1670-83. PubMed ID: 27034464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of lipoprotein lipase in 3T3-L1 adipocytes by angiopoietin-like protein 4 requires that both proteins have reached the cell surface.
    Makoveichuk E; Vorrsjö E; Olivecrona T; Olivecrona G
    Biochem Biophys Res Commun; 2013 Nov; 441(4):941-6. PubMed ID: 24220340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiac-Specific Overexpression of Oxytocin Receptor Leads to Cardiomyopathy in Mice.
    Jung C; Wernly B; Bjursell M; Wiseman J; Admyre T; Wikström J; Palmér M; Seeliger F; Lichtenauer M; Franz M; Frick C; Andersson AK; Elg M; Pernow J; Sjöquist PO; Bohlooly-Y M; Wang QD
    J Card Fail; 2018 Jul; 24(7):470-478. PubMed ID: 29802896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of lipoprotein lipase occurs on the surface of THP-1 macrophages where oligomers of angiopoietin-like protein 4 are formed.
    Makoveichuk E; Sukonina V; Kroupa O; Thulin P; Ehrenborg E; Olivecrona T; Olivecrona G
    Biochem Biophys Res Commun; 2012 Aug; 425(2):138-43. PubMed ID: 22820186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of angiopoietin-like protein 4 protects against atherosclerosis development.
    Georgiadi A; Wang Y; Stienstra R; Tjeerdema N; Janssen A; Stalenhoef A; van der Vliet JA; de Roos A; Tamsma JT; Smit JW; Tan NS; Müller M; Rensen PC; Kersten S
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1529-37. PubMed ID: 23640487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiac overexpression of hormone-sensitive lipase inhibits myocardial steatosis and fibrosis in streptozotocin diabetic mice.
    Ueno M; Suzuki J; Zenimaru Y; Takahashi S; Koizumi T; Noriki S; Yamaguchi O; Otsu K; Shen WJ; Kraemer FB; Miyamori I
    Am J Physiol Endocrinol Metab; 2008 Jun; 294(6):E1109-18. PubMed ID: 18413675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peroxisome proliferator-activated receptor agonists modulate heart function in transgenic mice with lipotoxic cardiomyopathy.
    Vikramadithyan RK; Hirata K; Yagyu H; Hu Y; Augustus A; Homma S; Goldberg IJ
    J Pharmacol Exp Ther; 2005 May; 313(2):586-93. PubMed ID: 15671204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid-lowering effects of anti-angiopoietin-like 4 antibody recapitulate the lipid phenotype found in angiopoietin-like 4 knockout mice.
    Desai U; Lee EC; Chung K; Gao C; Gay J; Key B; Hansen G; Machajewski D; Platt KA; Sands AT; Schneider M; Van Sligtenhorst I; Suwanichkul A; Vogel P; Wilganowski N; Wingert J; Zambrowicz BP; Landes G; Powell DR
    Proc Natl Acad Sci U S A; 2007 Jul; 104(28):11766-71. PubMed ID: 17609370
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.